Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study

PURPOSE: To evaluate the efficacy and safety of antiangiogenic agents (sorafenib and sunitinib) as postoperative adjuvant therapy in patients with nonmetastatic renal cell carcinoma (RCC) and venous tumor thrombus (VTT). MATERIAL AND METHODS: From March 2006 to January 2016, 147 patients who met the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Liangyou, Li, Hongzhao, Chen, Luyao, Li, Xintao, Wang, Baojun, Huang, Qingbo, Zhang, Fan, Fan, Yang, Gao, Yu, Peng, Cheng, Ma, Xin, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645483/
https://www.ncbi.nlm.nih.gov/pubmed/29035731
http://dx.doi.org/10.1016/j.tranon.2017.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645483/
https://www.ncbi.nlm.nih.gov/pubmed/29035731
http://dx.doi.org/10.1016/j.tranon.2017.09.009

Ejemplares similares